Merck KGaA (LON:0O14)

London flag London · Delayed Price · Currency is GBP · Price in EUR
120.65
+0.75 (0.63%)
At close: Dec 5, 2025
-15.04%
Market Cap 45.34B
Revenue (ttm) 18.57B
Net Income (ttm) 2.58B
Shares Out n/a
EPS (ttm) 5.93
PE Ratio 17.57
Forward PE 14.27
Dividend 1.87 (1.56%)
Ex-Dividend Date Apr 28, 2025
Volume 246
Average Volume 49,265
Open 119.20
Previous Close 119.90
Day's Range 119.10 - 121.65
52-Week Range 100.90 - 154.65
Beta 0.73
RSI 63.24
Earnings Date Nov 13, 2025

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany and internationally. It operates through Life Science, Healthcare, and Electronics segments. The Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as the industrial sector. This segment offers science and lab solutions comprising reagents, consumables, devices, instruments, software, and services for research, production, and testing; process solutions consisting of filtration devices, chromatography... [Read more]

Industry Pharmaceutical Preparations
Founded 1668
Employees 59,020
Stock Exchange London Stock Exchange
Ticker Symbol 0O14
Full Company Profile

Financial Performance

In 2024, Merck KGaA's revenue was 21.16 billion, an increase of 0.78% compared to the previous year's 20.99 billion. Earnings were 2.78 billion, a decrease of -1.66%.

Financial numbers in EUR Financial Statements

News

There is no news available yet.